Slow gait, white matter characteristics, and prior 10-year interleukin-6 levels in older adults

Neurology

Volumn 87, Issue 19, 2016, Pages 1993-1999

  Nadkarni, Neelesh K ^a,b   Boudreau, Robert M ^c   Studenski, Stephanie A ^f   Lopez, Oscar L ^b   Liu, Ge ^c   Kritchevsky, Stephen ^d   Yaffe, Kristine ^e   Newman, Anne B ^c   Rosano, Caterina ^c  

^a Department of Psychiatry and Behavioral Sciences   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; IL6 PROTEIN, HUMAN;

AGED; ARTICLE; CEREBROVASCULAR DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FRACTIONAL ANISOTROPY; HUMAN; HUMAN EXPERIMENT; LINEAR REGRESSION ANALYSIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; WALKING SPEED; WHITE MATTER; WHITE MATTER LESION; BLOOD; DIAGNOSTIC IMAGING; DIET RESTRICTION; INDEPENDENT LIVING; LONGITUDINAL STUDY; NEUROLOGIC EXAMINATION; NEUROLOGIC GAIT DISORDER; PATHOLOGY; PATHOPHYSIOLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ENZYME-LINKED IMMUNOSORBENT ASSAY; FASTING; FEMALE; GAIT DISORDERS, NEUROLOGIC; HUMANS; INDEPENDENT LIVING; INTERLEUKIN-6; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; NEUROLOGIC EXAMINATION; WHITE MATTER;

EID: 84994806211     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000003304     Document Type: Article

References (40)

1. Verghese J, Holtzer R, Oh-Park M, Derby CA, Lipton RB, Wang C. Inflammatory markers and gait speed decline in older adults. J Gerontol A Biol Sci Med Sci 2011;66: 1083-1089.
2. Cesari M, Penninx BW, Pahor M, et al. Inflammatory markers and physical performance in older persons: the InCHIANTI study. J Gerontol A Biol Sci Med Sci 2004;59:242-248.
3. Cesari M, Kritchevsky SB, Nicklas B, et al. Oxidative damage, platelet activation, and inflammation to predict mobility disability and mortality in older persons: results from the Health Aging and Body Composition Study. J Gerontol A Biol Sci Med Sci 2012;67:671-676.
4. Penninx BW, Kritchevsky SB, Newman AB, et al. Inflammatory markers and incident mobility limitation in the elderly. J Am Geriatr Soc 2004;52:1105-1113.
5. Jenny NS, French B, Arnold AM, et al. Long-term assessment of inflammation and healthy aging in late life: the Cardiovascular Health Study all stars. J Gerontol A Biol Sci Med Sci 2012;67:970-976.
6. Wright CB, Moon Y, Paik MC, et al. Inflammatory biomarkers of vascular risk as correlates of leukoariosis. Stroke 2009;40:3466-3471.
7. Fornage M, Chiang YA, O'Meara ES, et al. Biomarkers of inflammation and MRI-defined small vessel disease of the brain: the Cardiovascular Health Study. Stroke 2008;39: 1952-1959.
8. Satizabal CL, Zhu YC, Mazoyer B, Dufouil C, Tzourio C. Circulating IL-6 and CRP are associated with MRI findings in the elderly: the 3C-Dijon Study. Neurology 2012; 78:720-727.
9. Wersching H, Duning T, Lohmann H, et al. Serum Creactive protein is linked to cerebral microstructural integrity and cognitive function. Neurology 2010;74: 1022-1029.
10. Benson RR, Guttmann CR, Wei X, et al. Older people with impaired mobility have specific loci of periventricular abnormality on MRI. Neurology 2002;58:48-55.
11. Rosano C, Kuller LH, Chung H, Arnold AM, Longstreth WT Jr, Newman AB. Subclinical brain magnetic resonance imaging abnormalities predict physical functional decline in high-functioning older adults. J Am Geriatr Soc 2005;53:649-654.
12. Jones DK, Horsfield MA, Simmons A. Optimal strategies for measuring diffusion in anisotropic systems by magnetic resonance imaging. Magn Reson Med 1999; 42:515-525.
13. Gouw AA, Seewann A, Vrenken H, et al. Heterogeneity of white matter hyperintensities in Alzheimer's disease: postmortem quantitative MRI and neuropathology. Brain 2008;131:3286-3298.
14. Bolandzadeh N, Liu-Ambrose T, Aizenstein H, et al. Pathways linking regional hyperintensities in the brain and slower gait. Neuroimage 2014;99:7-13.
15. Van den Heuvel DM, ten Dam VH, de Craen AJ, et al. Increase in periventricular white matter hyperintensities parallels decline in mental processing speed in a nondemented elderly population. J Neurol Neurosurg Psychiatry 2006;77:149-153.
16. Bettcher BM, Yaffe K, Boudreau RM, et al. Declines in inflammation predict greater white matter microstructure in older adults. Neurobiol Aging 2015;36:948-954.
17. Simonsick EM, Newman AB, Nevitt MC, et al. Measuring higher level physical function in well-functioning older adults: expanding familiar approaches in the Health ABC study. J Gerontol A Biol Sci Med Sci 2001;56: M644-M649.
18. Yaffe K, Lindquist K, Penninx BW, et al. Inflammatory markers and cognition in well-functioning African-American and white elders. Neurology 2003;61:76-80.
19. Metti AL, Aizenstein H, Yaffe K, et al. Trajectories of peripheral interleukin-6, structure of the hippocampus, and cognitive impairment over 14 years in older adults. Neurobiol Aging 2015;36:3038-3044.
20. Venkatraman VK, Aizenstein HJ, Newman AB, et al. Lower digit symbol substitution score in the oldest old is related to magnetization transfer and diffusion tensor imaging of the white matter. Front Aging Neurosci 2011;3:11.
21. Wu M, Rosano C, Butters M, et al. A fully automated method for quantifying and localizing white matter hyperintensities on MR images. Psychiatry Res 2006;148: 133-142.
22. Zhang Y, Brady M, Smith S. Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm. IEEE Trans Med Imaging 2001;20:45-57.
23. Smith SM, Jenkinson M, Woolrich MW, et al. Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 2004;23(suppl 1):S208-S219.
24. Pierpaoli C, Basser PJ. Toward a quantitative assessment of diffusion anisotropy. Magn Reson Med 1996; 36:893-906.
25. Andersson JLR, Jenkinson M. Non-linear Registration, aka Spatial Normalisation: FMRIB Technical Report TR07JA2. Available at: fmrib.ox.ac.uk/analysis/techrep. Accessed July 6, 2016.
26. Barrick TR, Charlton RA, Clark CA, Markus HS. White matter structural decline in normal ageing: a prospective longitudinal study using tract-based spatial statistics. Neuroimage 2010;51:565-577.
27. Wakana S, Caprihan A, Panzenboeck MM, et al. Reproducibility of quantitative tractography methods applied to cerebral white matter. Neuroimage 2007;36:630-644.
28. Teng EL, Chui HC. The modified Mini-Mental State (3MS) examination. J Clin Psychiatry 1987;48:314-318.
29. Preacher KJ, Hayes AF. Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models. Behav Res Methods 2008;40:879-891.
30. Ferrucci L, Penninx BW, Volpato S, et al. Change in muscle strength explains accelerated decline of physical function in older women with high interleukin-6 serum levels. J Am Geriatr Soc 2002;50:1947-1954.
31. Taaffe DR, Harris TB, Ferrucci L, Rowe J, Seeman TE. Cross-sectional and prospective relationships of interleukin-6 and C-reactive protein with physical performance in elderly persons: MacArthur studies of successful aging. J Gerontol A Biol Sci Med Sci 2000;55: M709-M715.
32. De Groot M, Verhaaren BF, de Boer R, et al. Changes in normal-appearing white matter precede development of white matter lesions. Stroke 2013;44:1037-1042.
33. Erta M, Quintana A, Hidalgo J. Interleukin-6, a major cytokine in the central nervous system. Int J Biol Sci 2012;8:1254-1266.
34. Cunningham C, Maclullich AM. At the extreme end of the psychoneuroimmunological spectrum: delirium as a maladaptive sickness behaviour response. Brain Behav Immun 2013;28:1-13.
35. Aktas O, Ullrich O, Infante-Duarte C, Nitsch R, Zipp F. Neuronal damage in brain inflammation. Arch Neurol 2007;64:185-189.
36. Hsuchou H, Kastin AJ, Mishra PK, Pan W. C-reactive protein increases BBB permeability: implications for obesity and neuroinflammation. Cell Physiol Biochem 2012; 30:1109-1119.
37. Moscufo N, Guttmann CR, Meier D, et al. Brain regional lesion burden and impaired mobility in the elderly. Neurobiol Aging 2011;32:646-654.
38. Pantoni L, Garcia JH. Pathogenesis of leukoaraiosis: a review. Stroke 1997;28:652-659.
39. Bettcher BM, Watson CL, Walsh CM, et al. Interleukin-6, age, and corpus callosum integrity. PLoS One 2014;9: e106521.
40. Arfanakis K, Fleischman DA, Grisot G, et al. Systemic inflammation in non-demented elderly human subjects: brain microstructure and cognition. PLoS One 2013;8: e73107.